Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Chronic Pain and Hemophilia

Status of Chronic Pain in Patients With Hemophilia.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Hemophilia (A and B) are X-linked hereditary bleeding disorders whose severity depends on the level of coagulation factor (FVIII or FIX respectively). Bleeding is mainly from joints (hemarthrosis) and muscles (hematoma). Nowadays, treatment is based on preventive or curative intravenous infusion of coagulation factor concentrates. Despite these treatments, there is joint deterioration that can be responsible for hemophilic arthropathy and chronic pain. This pain may be related to excess nociception during acute bleeding, but it may also be neuropathic. There are only a few studies that have looked at pain in hemophilia, but it is accepted that the vast majority of patients (especially those with severe forms) suffer from chronic pain. Because patients have become accustomed to this pain and physicians are still not very aware of how to assess it, this pain is not treated effectively. In order to better manage pain in hemophilia, it is therefore necessary to characterize their pain and to know the nociceptive or neuropathic component. The aim of our study is therefore to study the prevalence, the nociceptive or neuropathic profile, the chronic aspect of pain and the main locations of pain in hemophilia. In addition to raising the awareness of physicians in the centers about pain management using specific questionnaires, this survey will help to better define chronic pain in hemophilia of all severities.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient with haemophilia of any severity, - Carrier female with low levels haemophilia (\< 40%), - ≥ 18 years of age and capable of giving willing to sign a consent form to participate in research. Who Should NOT Join This Trial: - Patient's refusal to participate in the survey, - Patient does not understand enough French (written and spoken) to complete the survey, - Patient unable to complete the survey for logistical reasons (lack of internet access), - Patient under protective measures (guardianship), - Patients with known addictive comorbidities and/or cognitive disorders. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient with haemophilia of any severity, * Carrier female with low levels haemophilia (\< 40%), * ≥ 18 years of age and capable of giving informed consent to participate in research. Exclusion Criteria: * Patient's refusal to participate in the survey, * Patient does not understand enough French (written and spoken) to complete the survey, * Patient unable to complete the survey for logistical reasons (lack of internet access), * Patient under protective measures (guardianship), * Patients with known addictive comorbidities and/or cognitive disorders.

Treatments Being Tested

OTHER

questionnaires

Electronic case report form integrating questionnaires on chronic pain related to haemophilia, associated-comorbidities, sociodemographic characteristics and analgesic treatments used.

Locations (10)

CHU de Bordeaux
Bordeaux, France
Centre Hospitalier Universitaire de Caen Normandie
Caen, France
CH Métropole Savoie
Chambéry, France
CHU de Clermont-Ferrand
Clermont-Ferrand, France
CHU de Grenoble
Grenoble, France
CHU de LILLE
Lille, France
Hospices Civils de Lyon
Lyon, France
Centre Hospitalier Universitaire de Nantes
Nantes, France
CHU de Saint-Etienne
Saint-Etienne, France
CHU de TOULOUSE
Toulouse, France